Lactose India [LACTOSE] vs Sun Pharma Advanced [SPARC] Detailed Stock Comparison

Lactose India Ltd.

BSE
Loading...

Sun Pharma Advanced Research Company Ltd.

NSE
Loading...

TLDR: Quick Comparison Summary

Based on 19 vital metrics comparison: Lactose India Ltd. wins in 15 metrics, Sun Pharma Advanced Research Company Ltd. wins in 3 metrics, with 0 ties. Lactose India Ltd. appears stronger overall.

View Metrics Details

Vital Metrics Comparison

Metric Lactose India Ltd. Sun Pharma Advanced Research Company Ltd. Better
P/E Ratio (TTM) 30.45 -13.65 Lactose India Ltd.
Price-to-Book Ratio 2.38 -13.55 Lactose India Ltd.
Debt-to-Equity Ratio 86.78 -1.21 Lactose India Ltd.
PEG Ratio 0.21 -11.15 Lactose India Ltd.
EV/EBITDA 12.54 -22.27 Lactose India Ltd.
Profit Margin (TTM) 3.32% -53.22% Lactose India Ltd.
Operating Margin (TTM) 4.45% -700.71% Lactose India Ltd.
EBITDA Margin (TTM) 4.45% N/A N/A
Return on Equity 8.79% 157.88% Sun Pharma Advanced Research Company Ltd.
Return on Assets (TTM) 3.87% -102.08% Lactose India Ltd.
Free Cash Flow (TTM) $-146.70M $-3.71B Lactose India Ltd.
1-Year Return 20.41% 14.56% Lactose India Ltd.
Price-to-Sales Ratio (TTM) 1.02 87.98 Lactose India Ltd.
Enterprise Value $1.98B $50.87B Sun Pharma Advanced Research Company Ltd.
EV/Revenue Ratio 1.36 95.73 Lactose India Ltd.
Gross Profit Margin (TTM) 27.83% -59.53% Lactose India Ltd.
Revenue per Share (TTM) $118 $2 Lactose India Ltd.
Earnings per Share (Diluted) $3.86 $-8.25 Lactose India Ltd.
Beta (Stock Volatility) 0.39 0.19 Sun Pharma Advanced Research Company Ltd.

Lactose India Ltd. vs Sun Pharma Advanced Research Company Ltd. Stock Performance Analysis

Loading Price Chart...

LACTOSE
SPARC

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
Lactose India Ltd.5.86%-1.16%2.18%27.09%4.75%9.98%
Sun Pharma Advanced Research Company Ltd.2.09%-5.81%49.25%68.87%37.58%54.41%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
Lactose India Ltd.20.41%127.85%280.87%63.03%1,621.05%19,298.31%
Sun Pharma Advanced Research Company Ltd.14.56%13.10%-5.14%-23.02%148.11%-27.03%

Performance & Financial Health Analysis: Lactose India Ltd. vs Sun Pharma Advanced Research Company Ltd.

MetricLACTOSESPARC
Market Information
Market Cap i₹1.48B₹46.75B
Market Cap CategorySmall capSmall cap
10 Day Avg. Volume i9,3462,401,062
90 Day Avg. Volume i7,2042,083,443
Last Close₹114.65₹208.50
52 Week Range₹76.01 - ₹136.70₹108.00 - ₹248.75
% from 52W High-16.13%-16.18%
All-Time High₹247.40 (Dec 09, 2024)₹875.00 (Apr 24, 2006)
% from All-Time High-53.66%-76.17%
Growth Metrics
Quarterly Revenue Growth0.28%-0.43%
Quarterly Earnings Growth1.42%-0.43%
Financial Health
Profit Margin (TTM) i0.03%-0.53%
Operating Margin (TTM) i0.04%-7.01%
Return on Equity (TTM) i0.09%1.58%
Debt to Equity (MRQ) i86.78-1.21
Cash & Liquidity
Book Value per Share (MRQ)₹49.43₹-10.63
Cash per Share (MRQ)₹3.25₹0.03
Operating Cash Flow (TTM) i₹-49,118,000₹-3,484,287,000
Levered Free Cash Flow (TTM) i₹51.63M₹-3,425,094,000
Dividends
Last 12-Month Dividend Yield iN/AN/A
Last 12-Month Dividend iN/AN/A

Valuation & Enterprise Metrics Analysis: Lactose India Ltd. vs Sun Pharma Advanced Research Company Ltd.

MetricLACTOSE (Apr 24, 2026)SPARC (Apr 22, 2026)
Price Ratios
P/E Ratio (TTM) i30.45-13.65
Forward P/E iN/A2.60
PEG Ratio i0.21-11.15
Price to Sales (TTM) i1.0287.98
Price to Book (MRQ) i2.38-13.55
Market Capitalization
Market Capitalization i₹1.48B₹46.75B
Enterprise Value i₹1.98B₹50.87B
Enterprise Value Metrics
Enterprise to Revenue i1.3695.73
Enterprise to EBITDA i12.54-22.27
Risk & Other Metrics
Beta i0.390.19
Book Value per Share (MRQ) i₹49.43₹-10.63

Financial Statements Comparison: Lactose India Ltd. vs Sun Pharma Advanced Research Company Ltd.

Financial Metrics

Loading Financial Charts...

Revenue

Operating Margin

Profit Margin

Long Term Debt

Income Flow Analysis

Financial Statements Comparison

Income Statement

MetricLACTOSE (2025)SPARC (2025)
Revenue/Sales i1.16B717.66M
Cost of Goods Sold i772.10M1.10B
COGS % of Revenue i66.4%153.2%
Gross Profit i390.56M-381.94M
Gross Margin i33.6%-53.2%
Research & Development iN/AN/A
Operating Income (EBIT) i115.95M-3.34B
Operating Margin i10.0%-465.5%
EBITDA i175.41M-3.23B
EBITDA Margin i15.1%-450.0%
Pre-Tax Income i69.18M-3.43B
Pre-Tax Income % of Revenue i5.9%-477.6%
Income Tax i17.55M-2.72M
Income Tax % of Revenue i1.5%-0.4%
Net Income (Profit) i51.63M-3.43B
Profit Margin i4.4%-477.3%

Balance Sheet & Liquidity Metrics

MetricLACTOSE (2025)SPARC (2025)
Cash & Equivalents i44.81M19.64M
Total Current Assets i573.26M261.97M
Total Current Assets % of Revenue i49.3%36.5%
Total Current Liabilities i448.90M3.74B
Total Current Liabilities % of Revenue i38.6%521.5%
Long-Term Debt i259.33M1.07B
Long-Term Debt % of Revenue i22.3%149.0%
Total Shareholders Equity i587.40M-2.17B
Retained Earnings i260.03M-23.22B
Retained Earnings % of Revenue i22.4%-3,235.0%
Property, Plant & Equipment i12.74M178.02M

Cash Flow Statement Comparison

MetricLACTOSE (2025)SPARC (2025)
Operating Cash Flow i-49.12M-3.48B
Operating Cash Flow % of Revenue i-4.2%-485.5%
Capital Expenditures i-139.17M-97.45M
Free Cash Flow i-146.70M-3.71B
FCF Margin i-12.6%-516.4%
Debt Repayment iN/A-3.69B
Common Stock Repurchase iN/AN/A

Short Interest & Institutional Ownership Analysis

MetricLACTOSESPARC
Shares Short iN/AN/A
Short Ratio iN/AN/A
Short % of Float iN/AN/A
Shares Outstanding i12.59M324.52M
Float Shares i5.19M91.32M
% Held by Insiders i58.73%72.96%
% Held by Institutions i0.00%2.56%
% Held by Public i41.27%24.48%

Dividend Analysis & Yield Comparison: Lactose India Ltd. vs Sun Pharma Advanced Research Company Ltd.

MetricLACTOSESPARC
Last 12-Month Dividend iN/AN/A
Last 12-Month Dividend Yield iN/AN/A
3-Year Avg Annual Dividend iN/AN/A
3-Year Avg Dividend Yield iN/AN/A
3-Year Total Dividends iN/AN/A
Ex-Dividend DateN/AN/A